Fortune's David Ewing Duncan asks whether a "marriage between pharma and biotech will create more drugs." Pharmaceutical companies, he notes, "are struggling to replenish research development pipelines," whereas biotech firms "have the best ideas for new drugs but are constantly short of cash." But as of the Biotechnology Industry Organization meeting in Chicago last week, he says, the two are coming together.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.